Neuralink Stock

Neuralink is a privately held company. Only accredited and institutional investors can invest in privately held companies before their IPO. Investors seeking exposure to pre-IPO companies such as Neuralink can invest via special purpose vehicles, funds, investment syndicates, or, purchase shares directly depending on the company's policy on stock transferability.

Due to regulations, only accredited and institutional investors are eligible to purchase the stock of private companies like Neuralink. Even then, most direct stock transfers must be approved by Neuralink itself. Some companies do not generally approve transfers of common shares. In such companies, investors might be able to get exposure to the company by investing indirectly through a fund or special purpose vehicle.

If you own Neuralink shares, you may be able to find a buyer on pre-IPO marketplaces or through a registered broker. Whether you can sell your shares ultimately depends on several factors such as the class of shares you own, the holding period prescribed by regulations, if applicable, and Neuralink's stance on share transfers as laid out in option agreements, option plans, company bylaws, shareholder agreements, or other company documents.

Want to learn more? Read this guide to selling pre-IPO shares and frequently asked questions.

As a privately held company, Neuralink has no public stock price. To access current and historical pricing information on Neuralink stock, you can review filings from the company's past primary funding rounds, fund marks, and information from secondary trading data providers. Hiive also offers free access to historical trading data on hundreds of the top pre-IPO companies such as Neuralink, based on its platform activity.

The valuation of private companies such as Neuralink is not readily available because they are not listed on public exchanges.

One source of information on Neuralink's valuation is the details of its most recent primary funding rounds. Financial and technology news sources such as Reuters, Bloomberg, Techcrunch, and The Information routinely report on private company funding rounds and can be a good source of information. Alternatively, you can look at Neuralink's official website for releases and investor relations updates, alongside venture capital databases such as Crunchbase, Pitchbook, and Preqin.

Neuralink remains a privately held company and cannot be accessed on major public exchanges such as NASDAQ or NYSE.

Accredited investors can invest in the top private companies like Neuralink before they IPO via secondary marketplaces such as Hiive.